رجوع
نطاق اليوم
KWD 2.49
KWD 2.64
نطاق 52 أسبوعًا
KWD 0.69
KWD 4.18
حجم التداول
3,764,442
متوسط 50 يوم / 200 يوم
KWD 3.18
/
KWD 2.62
الإغلاق السابق
KWD 2.62
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -24.0 | 0.3 |
| P/B | — | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | -5.6 | 3.8 |
| Rev Growth 5Y % | 50.6 | 10.0 |
| D/E | — | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 9.000
+243.5%
مكرر الربحية المستقبلي
35.5
ربحية السهم المستقبلية
KWD 0.074
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
410 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 1.670
KWD 1.269 – KWD 2.068
|
1.1 B | 1 |
| FY2029 |
KWD 1.170
KWD 0.889 – KWD 1.449
|
880 M | 1 |
| FY2028 |
KWD 0.342
-KWD 0.631 – KWD 1.170
|
550 M | 3 |
النقاط الرئيسية
Revenue grew 50.56% annually over 5 years — strong growth
Negative free cash flow of -12.90M
PEG of 0.56 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 29.25%
Capital efficient — spends only 0.05% of revenue on capex
ROIC of 18.37% — excellent capital efficiency
النمو
Revenue Growth (5Y)
50.56%
Revenue (1Y)21.31%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
N/A
ROIC18.37%
Net Margin-5.63%
Op. Margin14.95%
الأمان
Debt / Equity
N/A
Current Ratio0.56
Interest Coverage0.71
التقييم
P/E Ratio
-24.02
P/B RatioN/A
EV/EBITDA15.34
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 21.31% | Revenue Growth (3Y) | 86.15% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 50.56% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 403.14M | Net Income (TTM) | -22.68M |
| ROE | N/A | ROA | -4.87% |
| Gross Margin | 67.95% | Operating Margin | 14.95% |
| Net Margin | -5.63% | Free Cash Flow (TTM) | -12.90M |
| ROIC | 18.37% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.56 |
| Interest Coverage | 0.71 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -24.02 | P/B Ratio | N/A |
| P/S Ratio | 1.35 | PEG Ratio | 0.56 |
| EV/EBITDA | 15.34 | Dividend Yield | 0.00% |
| Market Cap | 544.72M | Enterprise Value | 924.87M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 403.14M | 332.31M | 116.33M | 75.48M | 78.45M |
| Net Income | -22.68M | -51.75M | -209.25M | -233.66M | -269.11M |
| EPS (Diluted) | -0.11 | -0.28 | -2.03 | -4.33 | -11.03 |
| Gross Profit | 273.91M | 263.71M | 73.07M | 48.51M | 64.23M |
| Operating Income | 60.27M | 54.40M | -155.56M | -179.50M | -226.73M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 465.89M | 343.82M | 205.80M | 247.94M | 381.59M |
| Total Liabilities | 767.85M | 732.54M | 660.79M | 571.72M | 578.53M |
| Shareholders' Equity | -301.97M | -388.72M | -454.99M | -323.78M | -196.94M |
| Total Debt | 548.00M | 591.21M | 540.95M | 260.95M | 260.20M |
| Cash & Equivalents | 167.85M | 144.76M | 82.25M | 124.78M | 208.89M |
| Current Assets | 167.85M | 338.00M | 201.07M | 246.68M | 328.97M |
| Current Liabilities | 300.81M | 246.23M | 156.22M | 92.31M | 73.35M |